想要這個藥的說明書，溶出曲線及檢測方式（中文的）   [更多]

求混合糖電解質(zhì)注射液的IMS全球銷售數(shù)據(jù)，日本的商品名：TRIFLUID Injection   [更多]

具體要求： 根據(jù)已知企業(yè)名稱（寫法不規(guī)范） 去CFDA http://app1.sfda.gov.cn/datasearchcnda/face3/base.jsp?tableId=25&tableName=TABLE25&title=%B9%FA%B2%FA%D2%A9%C6%B7&bcId=152904713761213296322795806604 或 藥智數(shù)據(jù)https://db.yaozh.com/pijian 查找對應(yīng)的規(guī)范企業(yè)名稱 無法確認(rèn)的需備注好原因 規(guī)范數(shù)據(jù)按照0.05元/條（10000條500元） 備注數(shù)據(jù)按照0.01元/條（10000條100元） 準(zhǔn)確率要求98%。   [更多]

文獻(xiàn)： 1、" Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature. " Pharmacotherapy 2007;27:290–8. Page RL, Schwiesow J, Hilts A. 2、Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol 2013;39:310–24. Vehreschild JJ, Birtel A, Vehreschild MJGT, et al. 3、Tarantino MD, Fogarty P, Mayer B, Vasey SY, Brainsky A. Efficacy of eltrombopag in management of bleeding symptoms associated with chronic immune thrombocytopenia. Blood Coagul Fibrinolysis. 2013 Apr;24(3):284-96. doi: 10.1097/MBC.0b013e32835fac99. 4、J Med Chem, 51: 4632～4640. Org. Process Res. Dev. 2019, 23, 9, 2057-2068 Pharmazie 73(9):494-497 · September 2018 5、中國醫(yī)藥工業(yè)雜志 2012， 43（8）， 644-646 6、精細(xì)化工中間體2013，43（2），46-48 7、精細(xì)化工中間體2011，41（4），46-48 8、中國現(xiàn)代應(yīng)用藥學(xué)2011，28（1），58-59 9、Chemical biology&Drug Design 2014, 83(3), 306-316 10、Letters in organic chemistry 2012, 9(4), 276-279 11、Medicines Evidence Commentary : Chronic kidney disease: calcium-based versus non-calcium-based phosphate binders Source: National Institute for Health and Care Excellence - NICE - 21 January 2014 - Publisher: National Institute for Health and Care Excellence (NICE) 12、double-blind comparison of calcium chloride and calcium gluconate therapies for hypocalcemia in critically ill children 13、J. Med. Chem. 2018, 61, 5304?5322. 14、Chem. Biol. Drug Des. 2014, 83, 306?316. 15、J. Pharm. Biomed. Anal. 2009, 50, 144?150. 16、Int. J. Pharm. Sci. 2016, 8, 97?102. 17、J. Pharm. Biomed. Anal. 2010, 52, 493?507. 18、Org. Process Res. Dev. 2013, 17, 1036?1041. 19、Beilstein J. Org. Chem. 2011, 7, 442? 495. 20、Bioorg. Med. Chem. Lett. 2014, 24, 1108?1110. 21、New Activated PEG Derivatives for Affinity Partitioning 22、Population incidence and mortality of sepsis in an urban African setting 2013-2016 23、Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in   [更多]

有生產(chǎn)許可證等必要資質(zhì)   [更多]

求IMS數(shù)據(jù)庫復(fù)方醋酸鈉林格注射液銷售數(shù)據(jù)，目前國內(nèi)獲批的此品種有兩個名字，希望能查全 復(fù)方醋酸鈉林格是大輸液，國內(nèi)的名字叫復(fù)方醋酸鈉林格注射液，也叫鈉鉀鎂鈣葡萄糖注射液，日本大冢上市的名字叫：電解質(zhì)輸液（1％ブドウ糖加酢酸リンゲル液），商品名叫：Physio 140 Injection（フィジオ140 輸液）   [更多]

求購“Citicoline”《 USP42-NF37 》的藥典標(biāo)準(zhǔn)一份.   [更多]

急需冷敷凝膠、冷敷貼及傷口敷料的一類醫(yī)療器械全套備案申請資料   [更多]

健脾益腎顆粒信息   [更多]

利可君片信息   [更多]